| Cash Flow | 2025-06-30 |
|---|---|
| Impairment expense | 2,690 |
| Bargain purchase gain | 1,693 |
| Net loss after taxes | -29,745 |
| Depreciation and amortization | 2,923 |
| Interest expense on lease liability | 278 |
| Acquisition costs | 3,341 |
| Gain on disposal of assets, net | 4,254 |
| Share-based compensation | 4,451 |
| Shares issued for settlement of accounts payable | -6,730 |
| Income tax benefit, net | -678 |
| Loss on sale of cryptocurrency assets | -35 |
| Accounts receivable, net | -2,969 |
| Inventories, net | -1,927 |
| Prepaid expenses and other assets | 10,019 |
| Accounts payable | 4,804 |
| Accrued liabilities | 70 |
| Operating leases, net | -82 |
| Deferred revenue | 509 |
| Net cash (used in) provided by operating activities | -15,744 |
| Capital expenditures | 0 |
| Payments to acquire assets | 0 |
| Cash acquired in business combination | 5,940 |
| Proceeds from sale of cryptocurrency assets | 2,041 |
| Purchase of cryptocurrency assets | 2,076 |
| Proceeds from sale of assets | 7,375 |
| Net cash provided by (used in) investing activities | 13,280 |
| Payment of lease liability | 0 |
| Proceeds from short term borrowings | 859 |
| Repayment of short-term borrowings | 1,662 |
| Proceeds from long-term borrowings | 2,470 |
| Repayment of long-term borrowings | 7,614 |
| Proceeds from private placements | 9,238 |
| Payments for share repurchases | 137 |
| Net cash provided by financing activities | 3,154 |
| Net increase (decrease) in cash and cash equivalents | 690 |
| Effect of exchange rate changes on cash | 116 |
| Cash and cash equivalents at beginning of period | 106 |
| Cash and cash equivalents at end of period | 912 |
SRx Health Solutions, Inc. (SRXH)
SRx Health Solutions, Inc. (SRXH)